Fundraising Fox

Bill Amsbaugh

Investor

Partner at Cure Ventures

Cambridge, Massachusetts

Writes $100K – $5M checks · typically $1.5M

About

Partner and Chief Technology Officer at Cure Ventures leading bioinformatics efforts, with 25 years combining analytical chemistry and computer science to accelerate drug discovery. Previously co-founded Precision Health Software and worked with Third Rock Ventures portfolio companies.

LinkedIn ↗X / Twitter ↗

Experience

  1. Cure VenturesChief Technology Officer, Partnercurrent2021 — presentBoston, MA
  2. Precision HealthSoftCo-Founder, Chief Technology Officer2018 — 2021Boston, MA
  3. Convergence Life Science Technologies, LLCFounder & Managing Director2013 — 2021Massachusetts
  4. PTPCloud Architect2019 — 2021Norwood, MA
  5. Constellation PharmaceuticalsDirector of Automation & Information Technology2012 — 2014Cambridge, MA
  6. Constellation PharmaceuticalsAssociate Director of Automation and Information Technology2008 — 2012
  7. Ore Pharmaceuticals (formerly Gene Logic)Senior Manager2005 — 2008Cambridge, MA
  8. Johnson & Johnson (Formerly Transform Pharmaceuticals)Team Leader/Senior Developer2002 — 2005Lexington, MA
  9. Comverse Technology, IncLead Software Engineer1999 — 2002Wakefield, Massachusetts, United States
  10. Cabot CorporationAnalytical Chemist1998 — 1999Billerica, MA

Education

  1. Boston UniversityMaster of Science (MS), Computer Science2004 — 2008
  2. Carnegie Mellon UniversityCertificate, SEI Software Architecture Professional2011 — 2013
  3. Boston UniversityGraduate Certificate, Digital Forensics2009 — 2010
  4. Western New England UniversityBachelor of Science (BS), Chemistry1994 — 1997

Skills & more

Artificial Intelligence (AI)Machine LearningDrug Discovery21GenomicsBioinformaticsBiotechnology20Software Architectural DesignNatural Language Processing (NLP)Scientific ComputingLife Sciences9Cloud ComputingInformatics3
+5 moreDrug DevelopmentR&DIT StrategyChemistryPharmaceutical Industry

From Bill's professional profile.

Same school

Also attended Boston University192

Aydin SenkutFounder & Managing Partner at FelicisVinnie LauriaFounding Partner at Golden Gate VenturesGil GorenPartner at 83NorthJames LindenbaumCo-founder at HeavybitDave BiscegliaVenture Partner at Founder CollectiveKatherine OgnibeneOperations Associate at Founder Collective

+ 186 more

Also attended Carnegie Mellon University209

Javier SolteroSenior Venture Partner at Felicis VenturesAvi BharadwajInvestment Director at Intel CapitalTejAdvisor at Clear VenturesOren EtzioniVenture Partner at Madrona Venture GroupDiana HuGeneral Partner at Y CombinatorVlad LoktevInvestor at Index Ventures

+ 203 more

Also attended Western New England University3

Larry DeroseFounder & CEO, AdvaStim, Inc. at AIFNathan RosenkranzInvestor at VU Venture PartnersDanielle CarrManaging Director of Human Resources at Deerpath

Shared employers

Also worked at Ore Pharmaceuticals (formerly Gene Logic)1

Lou TartagliaManaging Partner at Cure Ventures

Also worked at Johnson & Johnson (Formerly Transform Pharmaceuticals)128

Karthik ArdhanareeswaranInvestor at GV (Google Ventures)KobeFinance Director at Hummingbird VenturesMickelFinance & Risk Management at Hummingbird VenturesHal PazInvestor at Khosla VenturesAaron PriceCEO, TechUnited at Tech Council VenturesJung Lee, PhDVenture Partner at Adelphi Ventures Management, Llc

+ 122 more

Also worked at Comverse Technology, Inc14

Daniel MironovPartner at vgamesEliav AlalufVenture Partner at Follow[the]SeedFilip SirokyGeneral Partner at MitonCAlan LysneCo-Founder and Partner at Fastbreak VenturesOded EliashivInvestor at BuiltUp VenturesZach SelchCommercial Advisor at 2Flo Ventures

+ 8 more

Colleagues at Cure Ventures

Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
James Vath
Partner at Cure Ventures

Network5

David Fallace
Managing Partner at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
James Vath
Partner at Cure Ventures
Kenzie Maclsaac
Partner at Cure Ventures
May Han
Partner at Cure Ventures

Investors connected to Bill in public investor directories — a warm-intro map.